UBS Maintains a 'Buy' on Biogen (BIIB); Core Franchise Support Valuation; Pipeline Provides Upside Risk
Go back to UBS Maintains a 'Buy' on Biogen (BIIB); Core Franchise Support Valuation; Pipeline Provides Upside Risk| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 209.83 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $209.83 | 52 Week High | $333.65 | |||
| Open | $209.83 | 52 Week Low | $223.02 | |||
| Day High | $209.83 | P/E | 26.87 | |||
| Day Low | $209.83 | EPS | $7.81 | |||
| Volume | 207 | |||||
